1. Home
  2. KDP vs NTRA Comparison

KDP vs NTRA Comparison

Compare KDP & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Keurig Dr Pepper Inc.

KDP

Keurig Dr Pepper Inc.

HOLD

Current Price

$30.79

Market Cap

41.8B

ML Signal

HOLD

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$311.69

Market Cap

45.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KDP
NTRA
Founded
1981
2003
Country
United States
United States
Employees
N/A
6140
Industry
Beverages (Production/Distribution)
Medical Specialities
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
41.8B
45.3B
IPO Year
2007
2015

Fundamental Metrics

Financial Performance
Metric
KDP
NTRA
Price
$30.79
$311.69
Analyst Decision
Buy
Strong Buy
Analyst Count
15
15
Target Price
$32.27
$259.07
AVG Volume (30 Days)
12.4M
1.2M
Earning Date
04-23-2026
05-07-2026
Dividend Yield
3.18%
N/A
EPS Growth
45.71
0.65
EPS
0.24
N/A
Revenue
$16,603,000,000.00
$210,939,000.00
Revenue This Year
$58.73
$18.08
Revenue Next Year
$14.29
$19.65
P/E Ratio
$126.17
N/A
Revenue Growth
8.16
N/A
52 Week Low
$24.88
$156.71
52 Week High
$35.94
$326.03

Technical Indicators

Market Signals
Indicator
KDP
NTRA
Relative Strength Index (RSI) 52.00 66.20
Support Level $29.78 $186.96
Resistance Level $31.91 $326.03
Average True Range (ATR) 0.98 11.46
MACD 0.07 2.46
Stochastic Oscillator 50.17 82.40

Price Performance

Historical Comparison
KDP
NTRA

About KDP Keurig Dr Pepper Inc.

Keurig Dr Pepper was established in 2018 following a merger between Keurig Green Mountain Coffee and Dr Pepper Snapple. The company manufactures and distributes coffee systems (including coffee brewers and single-serve coffee pods) under the Keurig and Green Mountain brands, as well as ready-to-drink beverages including flavored (non-cola) sparkling soft drinks under well-known brands such as Dr Pepper, Snapple, and Canada Dry. On Aug. 25, 2025, the firm announced a definitive agreement to acquire coffeemaker JDE Peet's for $18 billion in cash, with the deal now scheduled to close in April 2026. Following the merger, it plans to split into two US-listed entities to focus on refreshment beverages in North America and global coffee separately.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: